跳至主要内容
临床试验/NCT04537416
NCT04537416进行中(未招募)不适用

Multidisciplinary Team-Based Study to Optimize the Evaluation and Treatment of Women With Thrombophilia and Recurrent Pregnancy Loss

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,000
试验地点
1
主要终点
Frequency of laboratory diagnosed thrombophilia

研究概览

简要总结

A PubMed search of "thrombophilia" and "infertility" yields only 98 articles, the majority found in foreign medical journals and subspecialty journals with narrow readerships. Outside of Assisted Reproduction Clinics at academic medical centers, health care providers have limited awareness of the literature supporting thrombophilia evaluation and treatment in patients with recurrent pregnancy loss. As a result, women may suffer through years of repeated miscarriages before a thrombophilia evaluation is performed. By the time thrombophilia has been diagnosed as the cause of recurrent pregnancy loss, couples have often exhausted their personal savings on costly assisted reproductive therapies and present frustrated and psychologically exhausted.

In this study, we will evaluate the frequency of thrombophilia as a cause of recurrent pregnancy loss and provide insights into our patient care experience at BWH.

详细描述

Study Design:

Over a 2-year period, we will perform a retrospective observational cohort analysis of 1000 patients referred to the BWH Center for Infertility and Reproductive Surgery for evaluation of recurrent pregnancy loss. This cohort will include a retrospective analysis of 200 infertility patients referred to Dr. Piazza's Cardiovascular Medicine clinic for evaluation of thrombophilia.

We will also enroll prospectively for 18 months patients referred to the BWH Center for Infertility and Reproductive Surgery for evaluation of recurrent pregnancy loss.

Study Population:

We will include a study population that is representative of the ethnic and racial diversity of women who receive care at BWH. We will not enroll post-menopausal women, men or children because recurrent pregnancy loss specifically affects women of child-bearing potential. We do not plan to enroll pregnant women because we are specifically focused on women with recurrent pregnancy loss presenting for assisted reproductive therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 18-40 years
  • 2 or more pregnancy losses (including chemical pregnancies but not ectopic pregnancy)
  • Evaluated at the BWH Center for Infertility and Reproductive Surgery or the Watkins Cardiovascular Clinic

排除标准

  • Infertility due to uterine factors (such as Asherman's Syndrome)
  • Known translocation carrier
  • Prior venous thromboembolism on anticoagulation
  • Abnormal uterine cavity on hysterosalpingogram/hysteroscopy

结局指标

主要结局

Frequency of laboratory diagnosed thrombophilia

时间窗: 1 year

Laboratory diagnosed acquired or inherited thrombophilia

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gregory Piazza, MD, MS

Associate Director, Thrombosis Research Group

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验